Jessica Tassan
Stock Analyst at Piper Sandler
(1.04)
# 3,545
Out of 4,711 analysts
60
Total ratings
29.79%
Success rate
-14.21%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Reiterates: Overweight | $11 → $13 | $9.44 | +37.71% | 5 | Dec 4, 2024 | |
| HCAT Health Catalyst | Reiterates: Overweight | $11 → $12 | $7.09 | +69.25% | 10 | Nov 26, 2024 | |
| CVS CVS Health | Maintains: Overweight | $72 → $64 | $44.36 | +44.27% | 4 | Nov 25, 2024 | |
| CI The Cigna Group | Reiterates: Overweight | $392 → $394 | $276.92 | +42.28% | 2 | Nov 5, 2024 | |
| HUM Humana | Downgrades: Neutral | $392 → $274 | $247.10 | +10.89% | 2 | Oct 3, 2024 | |
| OSCR Oscar Health | Reiterates: Overweight | $28 | $14.09 | +98.72% | 4 | Sep 10, 2024 | |
| MPLN MultiPlan | Reiterates: Neutral | $80 → $40 | $6.02 | +564.45% | 2 | Aug 7, 2024 | |
| ALHC Alignment Healthcare | Reiterates: Overweight | $8 → $10 | $10.61 | -5.75% | 4 | Aug 6, 2024 | |
| PINC Premier | Maintains: Neutral | $24 → $22 | $21.76 | +1.10% | 4 | May 8, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $566 → $571 | $500.13 | +14.17% | 4 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $15 | $3.48 | +331.03% | 4 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $23 | $57.83 | -60.23% | 3 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $40 | $25.16 | +58.98% | 4 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $66 → $70 | $44.98 | +55.62% | 4 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $100 → $70 | $7.87 | +789.45% | 2 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $33 | $11.41 | +189.22% | 2 | Nov 4, 2022 |
Teladoc Health
Dec 4, 2024
Reiterates: Overweight
Price Target: $11 → $13
Current: $9.44
Upside: +37.71%
Health Catalyst
Nov 26, 2024
Reiterates: Overweight
Price Target: $11 → $12
Current: $7.09
Upside: +69.25%
CVS Health
Nov 25, 2024
Maintains: Overweight
Price Target: $72 → $64
Current: $44.36
Upside: +44.27%
The Cigna Group
Nov 5, 2024
Reiterates: Overweight
Price Target: $392 → $394
Current: $276.92
Upside: +42.28%
Humana
Oct 3, 2024
Downgrades: Neutral
Price Target: $392 → $274
Current: $247.10
Upside: +10.89%
Oscar Health
Sep 10, 2024
Reiterates: Overweight
Price Target: $28
Current: $14.09
Upside: +98.72%
MultiPlan
Aug 7, 2024
Reiterates: Neutral
Price Target: $80 → $40
Current: $6.02
Upside: +564.45%
Alignment Healthcare
Aug 6, 2024
Reiterates: Overweight
Price Target: $8 → $10
Current: $10.61
Upside: -5.75%
Premier
May 8, 2024
Maintains: Neutral
Price Target: $24 → $22
Current: $21.76
Upside: +1.10%
UnitedHealth Group
Apr 17, 2024
Maintains: Overweight
Price Target: $566 → $571
Current: $500.13
Upside: +14.17%
Jan 9, 2024
Maintains: Overweight
Price Target: $12 → $15
Current: $3.48
Upside: +331.03%
Nov 10, 2023
Maintains: Neutral
Price Target: $21 → $23
Current: $57.83
Upside: -60.23%
Sep 12, 2023
Maintains: Overweight
Price Target: $43 → $40
Current: $25.16
Upside: +58.98%
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $44.98
Upside: +55.62%
Feb 27, 2023
Downgrades: Neutral
Price Target: $100 → $70
Current: $7.87
Upside: +789.45%
Nov 4, 2022
Maintains: Overweight
Price Target: $40 → $33
Current: $11.41
Upside: +189.22%